Macrogen Europe specializes in next-generation sequencing (NGS), microarrays, and bioinformatics, delivering high-quality data for genome, transcriptome, and epigenome profiling. Their advanced platforms and expert team support research in genomics, personalized medicine, and drug discovery. They offer whole genome and exome sequencing, RNA-seq, small RNA profiling, metagenomics, epigenetic studies, and long-read sequencing, as well as cutting-edge single-cell and spatial omics. Their services play a key role in drug repurposing, enabling transcriptomic profiling of drug responses, variant detection for pharmacogenomics, and single-cell analysis to identify pathway-specific effects.

Macrogen Europe’s headquarters are located on the grounds of the Amsterdam Medical Center in the Netherlands, in a new, state-of-the-art laboratory. It also has sequencing facilities in Maastricht (NL), Milan (IT), Roissy-en-France (FR), and local representatives across the region. They partner with top sequencing suppliers, Illumina, Pacbio, Oxford Nanopore Technologies and Ultima Genomics, enabling them to offer in-house sequencing services using the latest technology.